Chapter 14: Transcription: Synthesis of RNA

The process centers on RNA polymerases, enzymes that differ from DNA polymerases in their ability to initiate synthesis without primers but compensate with limited proofreading capacity. The chapter distinguishes between prokaryotic and eukaryotic transcription mechanisms, explaining how prokaryotes employ a single RNA polymerase directed by sigma factors to recognize promoter sequences such as the Pribnow box, while eukaryotes utilize three specialized polymerases: Polymerase I synthesizes ribosomal RNA, Polymerase II produces messenger RNA and regulatory microRNAs, and Polymerase III generates transfer RNA and 5S ribosomal RNA. Gene structure and regulation are explored through cis-acting DNA elements including promoters, enhancers, and promoter-proximal regions that influence transcription frequency, alongside trans-acting proteins called transcription factors that facilitate polymerase binding. In eukaryotes, transcription produces pre-messenger RNA that undergoes extensive post-transcriptional modifications including addition of a protective 5-prime methylated guanosine cap, attachment of a poly-adenine tail at the 3-prime terminus, and removal of introns through a spliceosome-mediated process. The chapter explains how spliceosomes, composed of small nuclear ribonucleoproteins, catalyze precise intron removal while preserving coding exons, and highlights exon shuffling as an evolutionary mechanism generating protein structural diversity. Specific RNA types receive detailed attention: ribosomal RNA synthesis occurs within the nucleolus through methylation-directed processing; transfer RNA adopts a characteristic cloverleaf secondary structure and undergoes post-transcriptional modifications including pseudouridine and dihydrouridine incorporation; and the universal CCA sequence added to transfer RNA's 3-prime end facilitates amino acid attachment. The chapter integrates clinical cases demonstrating transcriptional pathology: beta-thalassemia results from mutations disrupting the TATA box or polyadenylation signals, reducing globin chain production; rifampin selectively inhibits bacterial RNA polymerase enabling tuberculosis treatment; alpha-amanitin from death cap mushrooms irreversibly inactivates eukaryotic Polymerase II; and systemic lupus erythematosus represents an autoimmune condition targeting small nuclear ribonucleoproteins. Additional topics address repetitive DNA sequences including Alu elements and LINE sequences, their roles in gene regulation and association with genetic diseases like familial hypercholesterolemia and hemophilia, underscoring transcription's critical importance to human health.